Psychiatry MMC | A peer-reviewed journal providing evidence-based information to practicing clinicians

Site Search


Free NEI Membership Offer

Receive a free two-month membership term to NEI when you register on Psychiatry (Edgemont)'s website!

Click here for more info

Join our Facebook Group


Elizabeth Klumpp's Facebook Profile

Follow Us on Twitter

Follow Psych_Edgemont on Twitter

The Use of Placebo-Controlled Clinical Trials for the Approval of Psychiatric Drugs: Part II—Ethical Considerations Related to the Individual Participant

December 2009

by David Feifel, MD, PhD

Professor, Department of Psychiatry; Director, Neuropsychiatry and Behavioral Medicine Program; Director, UCSD Adult ADHD Program, University of California, San Diego Medical Center, San Diego, California


This is protected content.
:
:
Content Protected by SmartLogix

Popularity: 3% [?]

Share and Enjoy:
  • HealthRanker
  • Google Bookmarks
  • LinkedIn
  • Facebook
  • Digg
  • Yahoo! Buzz
  • StumbleUpon
  • del.icio.us
  • ThisNext



Related posts

coded by nessus

Posted in Research to Practice | No Comments »

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.